RAC 1.11% $1.83 race oncology ltd

Ann: Bisantrene shows potent anticancer activity in AML models, page-25

  1. 18,984 Posts.
    lightbulb Created with Sketch. 5728
    From my perspective the cellular pathway section is the most interesting. Yes we knew that bis and dec worked well together in AML, but how was not known. Mechanism of action understanding is very important for clinical development these days.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.